Polaris Inc. (PII)
NYSE: PII · Real-Time Price · USD
63.98
-0.67 (-1.04%)
May 18, 2026, 4:00 PM EDT - Market closed
Polaris Revenue
Polaris had revenue of $1.66B in the quarter ending March 31, 2026, with 8.00% growth. This brings the company's revenue in the last twelve months to $7.27B, up 4.30% year-over-year. In the year 2025, Polaris had annual revenue of $7.15B, down -0.33%.
Revenue (ttm)
$7.27B
Revenue Growth
+4.30%
P/S Ratio
0.49
Revenue / Employee
$507,117
Employees
14,500
Market Cap
3.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.15B | -23.40M | -0.33% |
| Dec 31, 2024 | 7.18B | -1.76B | -19.69% |
| Dec 31, 2023 | 8.93B | 345.40M | 4.02% |
| Dec 31, 2022 | 8.59B | 1.15B | 15.46% |
| Dec 31, 2021 | 7.44B | 1.16B | 18.43% |
| Dec 31, 2020 | 6.28B | -501.10M | -7.39% |
| Dec 31, 2019 | 6.78B | 704.00M | 11.58% |
| Dec 31, 2018 | 6.08B | 650.02M | 11.97% |
| Dec 31, 2017 | 5.43B | 911.85M | 20.19% |
| Dec 31, 2016 | 4.52B | -202.66M | -4.29% |
| Dec 31, 2015 | 4.72B | 239.64M | 5.35% |
| Dec 31, 2014 | 4.48B | 702.58M | 18.60% |
| Dec 31, 2013 | 3.78B | 567.29M | 17.67% |
| Dec 31, 2012 | 3.21B | 552.83M | 20.81% |
| Dec 31, 2011 | 2.66B | 665.81M | 33.44% |
| Dec 31, 2010 | 1.99B | 425.25M | 27.16% |
| Dec 31, 2009 | 1.57B | -382.36M | -19.63% |
| Dec 31, 2008 | 1.95B | 168.24M | 9.45% |
| Dec 31, 2007 | 1.78B | 123.49M | 7.45% |
| Dec 31, 2006 | 1.66B | -213.30M | -11.41% |
| Dec 31, 2005 | 1.87B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| THOR Industries | 9.93B |
| BRP Inc. | 6.22B |
| Brunswick | 5.52B |
| Harley-Davidson | 4.32B |
| LCI Industries | 4.17B |
| Patrick Industries | 3.94B |
| Winnebago Industries | 2.91B |
| Malibu Boats | 826.09M |
PII News
- 5 days ago - Encoded Therapeutics Presents New Clinical Data from POLARIS Phase 1/2 Trials of ETX101 Gene Therapy in Dravet Syndrome at the ASGCT 2026 Presidential Symposium - Business Wire
- 6 days ago - Behavox Extends Polaris Trade Surveillance to Prediction Markets, Expanding Risk Coverage to 10 Asset Classes - Business Wire
- 14 days ago - Polaris Declares Regular Cash Dividend - PRNewsWire
- 18 days ago - Polaris Transcript: AGM 2026 - Transcripts
- 18 days ago - Polaris price target raised to $70 from $58 at Citi - TheFly
- 19 days ago - Polaris price target raised to $73 from $66 at Raymond James - TheFly
- 19 days ago - Polaris price target raised to $65 from $64 at Roth Capital - TheFly
- 19 days ago - Polaris price target raised to $74 from $70 at BofA - TheFly